It has been suggested that systemic administration of TNF-α can induce cognitive impairment (70), while anti-TNF-α treatment yields favorable outcomes in diseases with cognitive decline due to neuroinflammation (71–73). This evidence concerns the gene TNF and Mental deterioration.